Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Mar 18, 2025
Management to Hold Investor Day Conference Call Today at 10:00am ET
DEER PARK, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended December 31, 2024.
Read more at globenewswire.com
